Sepsis and serum cytokine concentrations

Critical Care Medicine

Volumn 25, Issue 3, 1997, Pages 405-412

  Damas, Pierre ^a   Canivet, Jean Luc ^a   De Groote, Donat ^b   Vrindts, Yvonne ^b   Albert, Adelin ^a   Franchimont, Paul ^a   Lamy, Maurice ^a  

^a Centre Hospitalier Universitaire of Liège   (Belgium)

^b Medgenix   (Belgium)

Author keywords

cytokines; interleukin 6; interleukin 8; leukemia inhibitory factor; septic shock; severe sepsis; tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; LEUKEMIA INHIBITORY FACTOR; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; HYPERLACTATEMIA; HYPOXEMIA; LEUKOPENIA; MALE; MORTALITY; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK;

ACIDOSIS, LACTIC; ADULT; AGED; AGED, 80 AND OVER; APACHE; FEMALE; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPSIS; SINGLE-BLIND METHOD; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030898553     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199703000-00006     Document Type: Article

References (45)

1. Bone RC: Gram-negative sepsis: A dilemma of modern medicine. Clin Microbiol Rev 1993; 6:57-68
2. Members of The American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
3. Glauser MP, Zanetti G, Baumgartner JD, et al: Septic shock: Pathogenesis. Lancet 1991; 338:732-736
4. Tracey KJ, Lowry SF, Cerami A: Cachectin: A hormone that triggers acute shock and chronic cachexia. J Infect Dis 1988; 157:413-419
5. Tracey KJ, Beutler B, Lowry S, et al: Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234:470-474
6. Waage A, Esperik T: Interleukin-1 potentiates the lethal effect of tumor necrosis factor-α in mice. J Exp Med 1988; 167:1987-1992
7. Tracey KJ, Fong Y, Hesse D, et al: Anticachectin/TNF-α monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330: 662-664
8. Ohlsson K, Björk P, Bergeufeldt M, et al: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990; 348:550-552
9. Van Snick J: Interleukin-6. An overview. Am Rev Immunol 1990; 8:253-278
10. Hack CE, De Groot ER, Felt-Bersma RJF, et al: Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74:1704-1710
11. Damas P, Ledoux D, Nys M, et al: Cytokine serum level during severe sepsis in human. IL-6 as a marker of severity. Ann Surg 1992; 215:356-362
12. Peveri P, Walz A, Dewald B: A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988; 167:1547-1559
13. Van Zee KJ, DeForge LE, Fischer E, et al: IL-8 in septic shock, endotoxemia, and after IL-1 administration. J Immunol 1991; 146:3478-3482
14. Gearing DP: The leukemia inhibitory factor and its receptor. Adv Immunol 1993; 53:31-58
15. Pirenne J, Ribbens C, Medot M, et al: Adverse effect of abdominal surgery on interferon gamma production. 1994. Eur J Surg 1995; 161:77-83
16. De Groote D, Fauchet F, Jadoul M, et al: An ELISA for the measurement of human leukemia inhibitory factor in biological fluids and culture supernatants. J Immunol Methods 1994; 167:253-261
17. Albert A, Lesaffre E: Multiple group logistic discrimination. Computers and Mathematics with Applications 1986; 12:209-224
18. Albert A, Harris EK: Multivariate Interpretation of Clinical Laboratory Data. New York, Marcel Dekker, 1987, pp 73-97
19. Waage A, Brandtzaeg P, Halsteusen A, et al: The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 1989; 169:333-338
20. Calandra T, Baumgartner JD, Grau G, et al: Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. J Infect Dis 1990; 161:982-987
21. Damas P, Reuter A, Gysen P, et al: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17: 975-978
22. Girardin E, Grau G, Dayer JM, et al: Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988; 319:397-400
23. Offner F, Philippe J, Vogelaers D, et al: Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 1990; 116: 100-105
24. Van Zee KJ, Fischer E, Hawes A, et al: Effects of IL-8 administration in nonhuman primates. J Immunol 1992; 148: 1746-1752
25. Barrière SL, Lowry SF: An overview of mortality risk prediction in sepsis. Crit Care Med 1995; 23:376-393
26. Fisher CJ, Opal SM, Dhainaut JF, et al: Influence of an antitumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit Care Med 1993; 21:318-327
27. Abraham E, Wunderink R, Silverman H, et al: Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome. JAMA 1995; 273:934-941
28. Fisher CJ, Dhainaut JA, Opal SM, et al: Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. JAMA 1994; 271:1836-1843
29. 5, a monoclonal antibody to endotoxin: Results of a prospective, multicenter, randomized, controlled trial. Crit Care Med 1995; 23:994-1006
30. Cohen J: Novel pharmacological approaches to sepsis. Current Opinion in Anaesthesiology 1994; 7:141-145
31. Fink MP: Another negative clinical trial of a new agent for the treatment of sepsis: Rethinking the process of developing adjuvant treatments for serious infections. Crit Care Med 1995; 23:989-991
32. Bone RC: Sepsis and controlled clinical trials: The odyssey. Crit Care Med 1995; 23:1165-1166
33. Bone RC: Sepsis and controlled clinical trials: The odyssey continues. Crit Care Med 1995; 23:1313-1315
34. Deitch EA: Tumor necrosis factor as the proximal mediator of sepsis - Or this too will pass. Crit Care Med 1995; 23:1457-1458
35. Pinsky MR, Vincent JL, Deviere J, et al: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103:565-575
36. Lin R, Astiz M, Saxon J, et al: Relationship between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med 1994; 22: 1595-1602
37. Fasshender U, Pargger H, Müller W, et al: Interleukin-6 and acute-phase protein concentration in surgical intensive care unit patients: Diagnostic signs in nosocomial infection. Crit Care Med 1993; 21:1175-1180
38. Butler J, Chong GL, Baigrie RJ, et al: Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 1992; 53: 833-838
39. Calandra T, Gerain J, Heumann D, et al: High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value and interplay with other cytokines. Am J Med 1991; 91:23-29
40. Friedland JS, Suputtamongkol Y, Remick DG, et al: Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 1992; 60:2402-2408
41. Casey L, Blak RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the septic syndrome. Ann Intern Med 1993; 119:771-778
42. Miller EJ, Cohen AB, Nagao S, et al: Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146:427-432
43. Broaddus VC, Hebert CA, Vitangcol RV, et al: Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am Rev Respir Dis 1992; 146:825-830
44. Hack CE, Hart M, Strack van Schijndel RJM, et al: Interleukin-8 in sepsis: Relation to shock and inflammatory mediators. Infect Immun 1992; 60: 2835-2842
45. Waring P, Wycherley K, Cary D, et al: Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest 1992; 90:2031-2037